| MKVBX | TRWTX | MKVBX / TRWTX | |
| Total Expense Ratio | 0.96 | 0.76 | 126% |
| Annual Report Gross Expense Ratio | 0.99 | 0.76 | 130% |
| Fund Existence | 6 years | 34 years | - |
| Gain YTD | 11.800 | 13.508 | 87% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.31B | 4.32B | 169% |
| Annual Yield % from dividends | 3.10 | 3.43 | 91% |
| Returns for 1 year | 21.73 | 20.47 | 106% |
| Returns for 3 years | 55.45 | 53.74 | 103% |
| Returns for 5 years | 58.35 | 49.42 | 118% |
| Returns for 10 years | N/A | 112.38 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ANVIX | 30.72 | N/A | N/A |
| Virtus NFJ Large-Cap Value Fund Inst | |||
| BDHAX | 9.08 | N/A | N/A |
| BlackRock Dynamic High Income Inv A | |||
| PAGHX | 143.05 | N/A | N/A |
| Permanent Portfolio Aggressive Growth C | |||
| UPAAX | 23.06 | N/A | N/A |
| Upright Assets Allocation Plus | |||
| JAGLX | 87.72 | -0.68 | -0.77% |
| Janus Henderson Global Life Sciences T | |||